In-Vivo Bioimaging of Nanocarriers

In-Vivo Bioimaging of Nanocarriers

Author: ChemistryViews

Fluorescence bioimaging plays an important role in exploring the in vivo behavior of nanocarriers. However, various factors hinder the accuracy of fluorescent bioimaging, such as interference of the free probes, fluorescence quenching/saturation, and re-illumination. Conventional fluorescent probes emit signals even after being released from nanocarriers, which may affect the interpretation of the behaviors of the nanocarriers. Environment-responsive fluorescent probes with aggregation-caused quenching (ACQ) properties have improved imaging accuracy by reducing the signal interference caused by free probes. However, existing ACQ probes suffer from fluorescence re-illumination in vivo (pictured below).

Wei Wu, Weili Zhao, Fudan University, Shanghai, China, Defang Ouyang, Institute of Chinese Medical Sciences (ICMS), University of Macau, China, and colleagues have modified an aza-BODIPY framework to develop a series of novel absolute ACQ (aACQ) fluorophores with negligible fluorescence re-illumination, e.g., FD-B21 and FD-C7 (pictured at the top). In these fluorophores, enhanced hydrophobicity, planarity, and rigidity facilitate π-π stacking and improve the cohesion of quenched dye aggregates. This leads to significantly lower re-illumination.



Compared with common ACQ probes, the aACQ probes demonstrated enhanced resistance to fluorescence re-illumination in in vitro, in vivo, and cellular environments. The work could provide guidance for the future development of aACQ probes. The researchers believe novel aACQ probes may facilitate more accurate in vivo bioimaging of nanocarriers compared with conventional probes.


Leave a Reply

Kindly review our community guidelines before leaving a comment.

Your email address will not be published. Required fields are marked *